Cargando…

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors

BACKGROUND: Hodgkin lymphoma (HL) patients are at an increased risk of late adverse treatment effects. While published studies focussed on the risk of either subsequent malignant neoplasms (SMNs) or cardiovascular disease (CVD), we examined the combined burden from SMN and CVD. METHODS: In 2908 5-ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Simone, Schaapveld, Michael, van Nimwegen, Frederika A, Jóźwiak, Katarzyna, Lugtenburg, Pieternella J, Daniëls, Laurien A, Roesink, Judith M, van der Maazen, Richard W M, Kok, Wouter E M, Aleman, Berthe M P, van Leeuwen, Flora E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886118/ https://www.ncbi.nlm.nih.gov/pubmed/29381685 http://dx.doi.org/10.1038/bjc.2017.476

Ejemplares similares

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
por: Geurts, Yvonne M., et al.
Publicado: (2023)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Subsequent Malignant Neoplasms in Retinoblastoma Survivors
por: Fabius, Armida W. M., et al.
Publicado: (2021)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)
por: Krul, Inge M, et al.
Publicado: (2018)

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
por: Juul, Sidsel Jacobsen, et al.
Publicado: (2022)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022)

Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2021)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors
por: Roberti, Sander, et al.
Publicado: (2022)

Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands
por: Posthuma, Hidde L. A., et al.
Publicado: (2021)

P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
por: Mieras, Adinda, et al.
Publicado: (2022)

P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy
por: Russell, Nicola S., et al.
Publicado: (2017)

Primary therapy and survival among patients with nodular lymphocyte‐predominant Hodgkin lymphoma: a population‐based analysis in the Netherlands, 1993–2016
por: Posthuma, Hidde L. A., et al.
Publicado: (2019)

Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
por: Ykema, Berbel L. M., et al.
Publicado: (2020)

Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies
por: Boot, Max V., et al.
Publicado: (2022)

Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial
por: Starreveld, Daniëlle E. J., et al.
Publicado: (2018)

Electrolyte disorders secondary to venetoclax
por: van der Lubbe, Nils, et al.
Publicado: (2020)

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009
por: Duane, Frances K., et al.
Publicado: (2022)

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?
por: Stienen, J. J. C., et al.
Publicado: (2015)

Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years
por: Jacobse, Judy N., et al.
Publicado: (2019)

Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for Hodgkin lymphoma: a multicentre, matched cohort study
por: Harmeling, J. Xavier, et al.
Publicado: (2023)

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study
por: Busson, Raphaël, et al.
Publicado: (2019)

Prevention of Catheter-Related Bacteremia with a Daily Ethanol Lock in Patients with Tunnelled Catheters: A Randomized, Placebo-Controlled Trial
por: Slobbe, Lennert, et al.
Publicado: (2010)

Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors: A Cross-Sectional Study
por: Naaktgeboren, Willeke R., et al.
Publicado: (2022)

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
por: Jacobse, Judy N., et al.
Publicado: (2019)

Variation in guideline adherence in non-Hodgkin’s lymphoma care: impact of patient and hospital characteristics
por: Stienen, Jozette J.C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2eeppbmek3rk6901v2o933gna8